ERRATUM article

Front. Pharmacol., 25 February 2021

Sec. Drugs Outcomes Research and Policies

Volume 12 - 2021 | https://doi.org/10.3389/fphar.2021.654045

This article is part of the Research TopicDrug Repurposing for COVID-19 TherapyView all 50 articles

Erratum: A Retrospective Study on the Use of Chinese Patent Medicine in 24 Medical Institutions for COVID-19 in China

This article is an erratum on:

  1. A Retrospective Study on the Use of Chinese Patent Medicine in 24 Medical Institutions for COVID-19 in China

    1. Read original article
Frontiers Production Office Frontiers Production Office*
  • Frontiers Media SA, Lausanne, Switzerland

An Erratum on:
A Retrospective Study on the Use of Chinese Patent Medicine in 24 Medical Institutions for COVID-19 in China

by Zhang, N., Shi, N., Li, S., Liu, G., Han, Y., Liu, L., Zhang, X., Kong, X., Zhang, B., Yuan, W., Liu, Y., Deng, D., Zheng, M., Zhang, Y., Li, L., Wang, X., Wu, J., Lin, X., Nian, H., Wu, X., Wang, H., Liu, F., Wang, H., Wang, H., Liu, Y., Liu, L., Zeng, W., Yang, M., Wang, Y., Zhai, H., and Wang, Y. (2020). Front. Pharmacol. 11:574562. doi: 10.3389/fphar.2020.574562

Due to a production error, an incorrect Funding statement was used.

The correct Funding statement is “This study was funded by the National Key R&D Program of China (NO. 2019YFC1712000); Subject: Development of international standards for services in clinical pharmaceutical affairs of Chinese Patent Medicine and dispensing education (NO. 2019YFC1712002).”

The publisher apologizes for the mistake. The original version of this article has been updated.

Keywords: Chinese patent medicine, COVID-19, application regularity, correlative factor, retrospective analysis

Citation: Frontiers Production Office (2021) Erratum: A Retrospective Study on the Use of Chinese Patent Medicine in 24 Medical Institutions for COVID-19 in China. Front. Pharmacol. 12:654045. doi: 10.3389/fphar.2021.654045

Received: 15 January 2021; Accepted: 15 January 2021;
Published: 25 February 2021.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2021 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Production Office, cHJvZHVjdGlvbi5vZmZpY2VAZnJvbnRpZXJzaW4ub3Jn

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.